Filing Details

CUSIP No. 65341U104

13G

1.

NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

Albert Einstein College of Medicine, Inc.

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(see instructions)

(a)         .

(b)         .

3.

SEC USE ONLY

4.

CITIZENSHIP OR PLACE OF ORGANIZATION

New York, United States

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH

5.

SOLE VOTING POWER

8,333,647 

6.

SHARED VOTING POWER

0

7.

SOLE DISPOSITIVE POWER

8,333,647

8.

SHARED DISPOSITIVE POWER

0

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

8,333,647

10.

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions)          .

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

13.0%*

12.

TYPE OF REPORTING PERSON (see instructions)

CO

* Percentage calculated based on 64,300,000 shares of Common Stock outstanding, as reported by the Issuer on its Form 8-K/A filed with the Securities and Exchange Commission on June 16, 2016.

CUSIP No. 65341U104

13G

(a)

Name of Issuer

Nexus BioPharma, Inc.

(b)

Address of Issuers Principal Executive Offices

8 Hillside Ave., Suite 108

Montclair, NJ 07042

(a)

Name of Person Filing

Albert Einstein College of Medicine, Inc.

(b)

Address of the Principal Office or, if none, residence

1300 Morris Park Avenue

Bronx, NY 10461

(c)

Citizenship

New York, United States

(d)

Title of Class of Securities

Common Stock, par value $0.001 per share

(e)

CUSIP Number

65341U104

(a)

      .

Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

(b)

      .

Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

(c)

      .

Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

(d)

      .

Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

(e)

      .

An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);

(f)

      .

An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);

(g)

      .

A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);

(h)

      .

A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i)

      .

A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j)

      .

Group, in accordance with §240.13d-1(b)(1)(ii)(J).

CUSIP No. 65341U104

13G

(a)

Amount beneficially owned: 

Albert Einstein College of Medicine, Inc. is the record owner of 8,333,647 shares of Common Stock as of June 9, 2016.  Albert Einstein College of Medicine, Inc., a New York not-for-profit corporation, is a private, non-profit medical school.  Jed M. Shivers, in his capacity as Associate Dean for Finance and Administration of Albert Einstein College of Medicine, Inc., has voting and dispositive power over the shares held by the Reporting Person.  Mr. Shivers disclaims beneficial ownership of the shares.

(b)

Percent of class:

13.0%.  The percentage is calculated based on 64,300,000 shares of Common Stock outstanding, as reported by the Issuer on its Form 8-K/A filed with the Securities and Exchange Commission on June 16, 2016.

(c)

Number of shares as to which the person has:  

(i)

Sole power to vote or to direct the vote:  8,333,647

(ii)

Shared power to vote or to direct the vote:  0

(iii)

Sole power to dispose or to direct the disposition of:  8,333,647

(iv)

Shared power to dispose or to direct the disposition of:  0

Date:

June 20, 2016

ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.

By:

 /s/ Jed M. Shivers

Name:  Jed M. Shivers

Title:  Associate Dean for Finance and Administration